Transgene SA (TRGNF)
0.80
0.00 (0.00%)
USD |
OTCM |
Oct 09, 16:00
Transgene Debt to Equity Ratio
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| December 31, 2011 | 0.0068 |
| June 30, 2011 | |
| December 31, 2010 | 0.0051 |
| June 30, 2010 | |
| December 31, 2009 | |
| June 30, 2009 | |
| December 31, 2008 | |
| June 30, 2008 | |
| December 31, 2007 |
| Date | Value |
|---|---|
| June 30, 2007 | |
| December 31, 2006 | |
| June 30, 2006 | |
| December 31, 2005 | |
| June 30, 2005 | |
| December 31, 2004 | 0.1415 |
| June 30, 2004 | |
| June 30, 2003 | 0.00 |
| December 31, 2001 | 0.0368 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Cellectis SA | 2.539 |
| Compugen Ltd. | 0.0341 |
| Evaxion AS | 0.7455 |
| Halozyme Therapeutics, Inc. | 14.95 |
| AVITA Medical, Inc. | -1.742 |